Valuation: Bould Opportunities PLC

Market Cap 5.71K 5.08K 4.7K 4.26K 8.02K 539K 8.12K 56.35K 22.11K 283K 21.41K 20.96K 902K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -69.71K -64.5K -58.46K -110K -7.39M -111K -773K -303K -3.88M -294K -288K -12.38M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 2021-05-13
Chief Tech/Sci/R&D Officer 61 2025-01-01
Director TitleAgeSince
Director/Board Member 45 2019-01-28
Chairman 70 2019-05-20
Director/Board Member 61 2021-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
+0.73%+2.09%+3.99%+56.67% 39.76B
-1.16%+1.59%-26.63%+33.36% 36.9B
+0.22%+3.33%-7.46%+33.99% 21.86B
+1.01%-7.86%+36.65%+53.71% 18.96B
-0.13%+6.91%+8.51%+49.48% 14.66B
+0.09%+3.42%+3.27%+38.15% 13.46B
-1.43%-6.44%-45.74%-60.22% 10.85B
-0.12%+2.58%-8.87%+18.93% 9.81B
+1.85%+5.19%-13.06%+89.72% 9.25B
Average +0.11%+3.41%-5.48%+34.87% 17.55B
Weighted average by Cap. +0.06%+1.18%-4.71%+39.01%

Financials

2019 2020
Net sales - -
Net income -832K -741K -685K -621K -1.17M -78.58M -1.18M -8.21M -3.22M -41.23M -3.12M -3.06M -132M -306K -272K -252K -228K -430K -28.9M -435K -3.02M -1.19M -15.16M -1.15M -1.12M -48.37M
Net Debt -378K -337K -311K -282K -531K -35.7M -538K -3.73M -1.46M -18.73M -1.42M -1.39M -59.76M -84K -74.79K -69.2K -62.72K -118K -7.93M -120K -829K -325K -4.16M -315K -309K -13.28M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-